ELMSFORD, N.Y., July 1, 2026 — SeeQC matters today because its Nasdaq debut is not shaping up as a plain venture-backed quantum IPO. The live SEC record shows a hybrid transaction: the public S-1 is still missing a disclosed price range, while the SEC’s June 30 effectiveness notice covered SeeQC’s S-4, and the company followed on July 1 with a 424B3 merger prospectus. That makes this less a clean IPO launch than a financing package that still has to carry a business-combination closing over the line.

The key point for IPO readers is that the IPO is not optional in this structure. In the January merger filing, Allegro and SeeQC said the transaction included a roughly $65 million PIPE and a separate firm-commitment public offering expected to close concurrently with the merger. The later 424B3 prospectus goes further: the PIPE is conditioned on SeeQC completing a public offering with gross proceeds of at least the lesser of 150% of the subscription-agreement proceeds and $75 million, at a public offering price of at least $6.50 a share. IPOGrid reads that as the real headline. Public investors are not just funding growth; they are helping satisfy a closing condition in a transaction with more moving pieces than the typical new issue.

The timing pressure is real as well. The merger agreement summary says either side can walk if the deal is not consummated by July 31, 2026, subject to extension mechanics. That gives SeeQC only a narrow window to translate an effective S-4 and an unpriced S-1 into an actual book. Our interpretation is that this compressed schedule is more important than the form labels themselves: a 424B3 here does not mean a conventional IPO has already been priced.

There is real company substance behind the financing complexity. On its website, SeeQC pitches itself as the first company to put all core functions of a quantum computer on a digital chip, and says its architecture combines qubits and classical logic in one cryogenic system. Two weeks before the S-1 went public, SeeQC also said it had been selected for a CHIPS Act-backed NORDTECH quantum R&D program tied to 300mm wafer-scale superconducting fabrication. That is useful color because it suggests the company can show more than lab rhetoric, even if public-market investors will still have to decide how much value to place on early positioning in quantum hardware infrastructure.

The financial texture remains early-stage. The S-1 shows 2025 revenue of $4.157 million, up from $0.8 million in 2024, but also a net loss of $12.2 million last year after a $10.1 million loss in 2024. For the three months ended March 31, 2026, revenue slipped to $856,000 from $978,000 a year earlier while the quarterly loss widened to $4.9 million from $2.1 million. The same filing says SeeQC had $23.1 million of cash at March 31 and an accumulated deficit of $60.5 million, while management still argues existing cash can fund operations for at least the next 12 months. The reviewer’s concern is not immediate insolvency; it is that the public pitch still asks investors to underwrite a business that remains small, lossmaking, and heavily tied to government and government-adjacent contract work.

That government mix cuts both ways. The S-1 says revenue from the U.S. government and its agencies was $2.2 million of 2025 revenue, versus $0.3 million in 2024, and $0.9 million in the March 2026 quarter versus $1.0 million a year earlier. For a quantum infrastructure company, that kind of customer validation is better than pure concept-stage storytelling. But IPOGrid would frame it as concentration risk as well: public investors are still being asked to back a company whose commercial scale outside research, defense, and custom fabrication channels has not yet been proven.

The bank group gives the deal some shape, but not yet the certainty of a normal calendar IPO. SeeQC’s June 29 offering announcement named Cantor and BTIG as lead book-running managers, and the S-1 cover also includes Needham & Company and Craig-Hallum. But the same S-1 still left the share count and price range blank, and the merger prospectus carries a sizable post-close incentive structure, including earnout tranches of 20 million shares each tied to $6.50, $8.00, and $10.00 stock-price targets. That structure appears to us to be the right lens for the story: SeeQC is one of the more interesting quantum names trying to reach Nasdaq this year, but the market is being asked to finance a concurrent listing and merger close, not simply to price a clean standalone IPO.